selected publications

• article

  • Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: An across-study comparison.  RMD Open.  7:-. 2021-01-01
  • Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.  The Lancet Rheumatology.  3:e122-e130. 2021-01-01
  • Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: Results from a randomised, placebo-controlled trial.  Annals of the Rheumatic Diseases.  79:1340-1348. 2020-01-01